Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System
Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System
Data
2015
Autores
Pinto, Márcia
Entringer, Aline Piovezan
Steffen, Ricardo
Trajman, Anete
Journal Title
Journal ISSN
Volume Title
Publisher
Jornal Brasileiro de Pneumologia
Resumo
We estimated the costs of a molecular test for Mycobacterium tuberculosis and resistance
to rifampin (Xpert MTB/RIF) and of smear microscopy, within the Brazilian Sistema Único
de Saúde (SUS, Unified Health Care System). In SUS laboratories in the cities of Rio
de Janeiro and Manaus, we performed activity-based costing and micro-costing. The
mean unit costs for Xpert MTB/RIF and smear microscopy were R$35.57 and R$14.16,
respectively. The major cost drivers for Xpert MTB/RIF and smear microscopy were
consumables/reagents and staff, respectively. These results might facilitate future cost-
effectiveness studies and inform the decision-making process regarding the expansion
of Xpert MTB/RIF use in Brazil.
Description
Palavras-chave
Costs and cost analysis, Tuberculosis, Nucleic acid amplification techniques
Citação
Pinto M, Entringer AP, Steffen R, Trajman A. Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System. J Bras Pneumol. 2015 Nov-Dec;41(6):536-8. doi: 10.1590/S1806-37562015000004524. Erratum in: J Bras Pneumol. 2016 Jan-Feb;42(1):79. doi: 10.1590/S1806-37562016000004524errata.